Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma.
Waizenegger JS, Ben-Batalla I, Weinhold N, Meissner T, Wroblewski M, Janning M, Riecken K, Binder M, Atanackovic D, Taipaleenmaeki H, Schewe D, Sawall S, Gensch V, Cubas-Cordova M, Seckinger A, Fiedler W, Hesse E, Kröger N, Fehse B, Hose D, Klein B, Raab MS, Pantel K, Bokemeyer C, Loges S. Waizenegger JS, et al. Among authors: gensch v. Leukemia. 2015 Mar;29(3):696-704. doi: 10.1038/leu.2014.236. Epub 2014 Aug 8. Leukemia. 2015. PMID: 25102945
Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma.
Waizenegger JS, Ben-Batalla I, Weinhold N, Meissner T, Wroblewski M, Janning M, Riecken K, Binder M, Atanackovic D, Taipaleenmaeki H, Schewe D, Sawall S, Gensch V, Cubas-Cordova M, Seckinger A, Fiedler W, Hesse E, Kröger N, Fehse B, Hose D, Klein B, Raab MS, Pantel K, Bokemeyer C, Loges S. Waizenegger JS, et al. Among authors: gensch v. Leukemia. 2020 Sep;34(9):2542. doi: 10.1038/s41375-020-0781-5. Leukemia. 2020. PMID: 32127637
Cyclooxygenase-2 blockade can improve efficacy of VEGF-targeting drugs.
Ben-Batalla I, Cubas-Cordova M, Udonta F, Wroblewski M, Waizenegger JS, Janning M, Sawall S, Gensch V, Zhao L, Martinez-Zubiaurre I, Riecken K, Fehse B, Pantel K, Bokemeyer C, Loges S. Ben-Batalla I, et al. Among authors: gensch v. Oncotarget. 2015 Mar 20;6(8):6341-58. doi: 10.18632/oncotarget.3437. Oncotarget. 2015. PMID: 25849942 Free PMC article.
BET-inhibition by JQ1 promotes proliferation and self-renewal capacity of hematopoietic stem cells.
Wroblewski M, Scheller-Wendorff M, Udonta F, Bauer R, Schlichting J, Zhao L, Ben Batalla I, Gensch V, Päsler S, Wu L, Wanior M, Taipaleenmäki H, Bolamperti S, Najafova Z, Pantel K, Bokemeyer C, Qi J, Hesse E, Knapp S, Johnsen S, Loges S. Wroblewski M, et al. Among authors: gensch v. Haematologica. 2018 Jun;103(6):939-948. doi: 10.3324/haematol.2017.181354. Epub 2018 Mar 22. Haematologica. 2018. PMID: 29567778 Free PMC article.
AXL Inhibition Represents a Novel Therapeutic Approach in BCR-ABL Negative Myeloproliferative Neoplasms.
Beitzen-Heineke A, Berenbrok N, Waizenegger J, Paesler S, Gensch V, Udonta F, Vargas Delgado ME, Engelmann J, Hoffmann F, Schafhausen P, von Amsberg G, Riecken K, Beumer N, Imbusch CD, Lorens J, Fischer T, Pantel K, Bokemeyer C, Ben-Batalla I, Loges S. Beitzen-Heineke A, et al. Among authors: gensch v. Hemasphere. 2021 Aug 11;5(9):e630. doi: 10.1097/HS9.0000000000000630. eCollection 2021 Sep. Hemasphere. 2021. PMID: 34396051 Free PMC article.
Blockade of Myeloid-Derived Suppressor Cell Expansion with All-Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy.
Bauer R, Udonta F, Wroblewski M, Ben-Batalla I, Santos IM, Taverna F, Kuhlencord M, Gensch V, Päsler S, Vinckier S, Brandner JM, Pantel K, Bokemeyer C, Vogl T, Roth J, Carmeliet P, Loges S. Bauer R, et al. Among authors: gensch v. Cancer Res. 2018 Jun 15;78(12):3220-3232. doi: 10.1158/0008-5472.CAN-17-3415. Epub 2018 Apr 19. Cancer Res. 2018. PMID: 29674477
Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial.
Janning M, Müller V, Vettorazzi E, Cubas-Cordova M, Gensch V, Ben-Batalla I, Zu Eulenburg C, Schem C, Fasching PA, Schnappauf B, Karn T, Fehm T, Just M, Kühn T, Holms F, Overkamp F, Krabisch P, Rack B, Denkert C, Untch M, Tesch H, Rezai M, Kittel K, Pantel K, Bokemeyer C, Loibl S, von Minckwitz G, Loges S. Janning M, et al. Among authors: gensch v. Int J Cancer. 2019 Aug 1;145(3):857-868. doi: 10.1002/ijc.32163. Epub 2019 Mar 4. Int J Cancer. 2019. PMID: 30694523 Clinical Trial.
A Trithia-Bridged N-Heterotriangulene: The Hitherto Missing Electron Donor.
Borstelmann J, Gensch V, Fehn D, Miehlich ME, Hampel F, Rominger F, Meyer K, Kivala M. Borstelmann J, et al. Among authors: gensch v. Angew Chem Int Ed Engl. 2024 Dec 16:e202423802. doi: 10.1002/anie.202423802. Online ahead of print. Angew Chem Int Ed Engl. 2024. PMID: 39679870
Regulation of bone homeostasis by MERTK and TYRO3.
Engelmann J, Zarrer J, Gensch V, Riecken K, Berenbrok N, Luu TV, Beitzen-Heineke A, Vargas-Delgado ME, Pantel K, Bokemeyer C, Bhamidipati S, Darwish IS, Masuda E, Burstyn-Cohen T, Alberto EJ, Ghosh S, Rothlin C, Hesse E, Taipaleenmäki H, Ben-Batalla I, Loges S. Engelmann J, et al. Among authors: gensch v. Nat Commun. 2022 Dec 12;13(1):7689. doi: 10.1038/s41467-022-33938-x. Nat Commun. 2022. PMID: 36509738 Free PMC article.
11 results